Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics (MLYS) is seeing increased social media buzz around its Phase [--] trials, with top creators highlighting upcoming catalysts. Despite this, recent price action shows volatility near its 52-week high.

About Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular and renal diseases.
Mineralys Therapeutics, Inc. uses the ticker $MLYS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Mineralys Therapeutics, Inc. (MLYS) social dominance is up 76.79% from the previous week.
Mineralys Therapeutics, Inc. (MLYS) creators is up 77.63% from the previous month.
Mineralys Therapeutics, Inc. (MLYS) engagements is up 47.91% from the previous week.
Mineralys Therapeutics, Inc. (MLYS) mentions is up 105.77% from the previous month.
Mineralys Therapeutics, Inc. (MLYS) posts created is up 166.67% from the previous week.

Price: $27.60

Price 24-Hour Time-Series Raw Data
The stock price is experiencing volatility near its 52-week high, potentially due to decreased social mentions and creator activity, suggesting a short-term correction despite positive trial results and analyst upgrades.

24-Hour: 0.99% 7-Day: -8.82% 30-Day: -15.7%

1-Year High: $47.30 on 2025-11-12
1-Year Low: $8.80 on 2025-02-25

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Mineralys Therapeutics, Inc. (MLYS) is currently AltRank #987 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] +62
[--] Month: [---] +875
[--] Months: [---] +185
[--] Year: [---] +362
1-Year High: [-----] on 2025-11-06
1-Year Low: [--] on 2025-09-21

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-03-10
1-Year Low: [--] on 2025-04-25

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +48%
[--] Month: [-------] -7.50%
[--] Months: [---------] +52%
[--] Year: [---------] +157%
1-Year High: [-------] on 2025-09-02
1-Year Low: [---] on 2025-08-09

Engagements by network (24h): YouTube: [--] Reddit: [--] X: [-----]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +29%
[--] Month: [---] +106%
[--] Months: [-----] +61%
[--] Year: [-----] +779%
1-Year High: [---] on 2025-09-03
1-Year Low: [--] on 2025-08-09

Mentions by network (24h): YouTube: [--] Reddit: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Mineralys Therapeutics, Inc. (MLYS) in the last [--] hours which is down 72% from [---] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +24%
[--] Month: [---] +78%
[--] Months: [---] -7.30%
[--] Year: [-----] +687%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-08-18

The most influential creators that mention Mineralys Therapeutics, Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@Andre_AGTC	[--]	[-----]	[--]	[---]
@Mineralystx	[--]	[---]	[--]	[--]
@Ellie18153	[--]	[--]	[--]	[--]
@TreyHendrickzyn	[--]	[---]	[--]	[--]
@David_Tonkinn	[--]	[--]	[--]	[--]
@PersimmonTI	[--]	[------]	[--]	[--]
@Angelinafrazier	[--]		[--]	[--]
@it2mr0	[--]	[-----]	[--]	[--]
@Stock_Analysis8	[--]	[--]	[--]	[--]

Sentiment: 50%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 50%
Daily Average: 77%
[--] Week: 67% -33%
[--] Month: 43% +3%
[--] Months: 43% -57%
[--] Year: 43% -57%
1-Year High: 100% on 2025-02-17
1-Year Low: 15% on 2025-12-29

Most Supportive Themes:

Director Share Purchase: (40%) Director Srinivas Akkaraju purchased $15M in shares, signaling confidence.

Most Critical Themes:

Declining Social Activity: (30%) Mentions of MLYS are down 77% and creators mentioning MLYS are down 84% over the last month.

Social Dominance: 0.00442%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00442%
Daily Average: 0.00905%
[--] Week: 0.0099% +0.0043%
[--] Month: 0.0017% -0.021%
[--] Months: 0.0017% -0.0014%
[--] Year: 0.0017% -0.006%
1-Year High: 0.061% on 2025-09-03
1-Year Low: 0.0013% on 2025-08-09

Market Dominance: 0.00251%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00251%
Daily Average: 0%
1-Year High: 0.00448% on 2025-11-12
1-Year Low: 0.00251% on 2026-02-15

Market Cap: $2,215,918,768

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,215,918,768
Daily Average: $2,948,018,489
[--] Week: $2,215,918,768 -11%
[--] Month: $2,184,262,786 -16%
1-Year High: $3,745,694,117 on 2025-11-12
1-Year Low: $2,184,262,786 on 2026-02-13

Top Mineralys Therapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, [----] engagements

"My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3"
X Link @Andre_AGTC 2026-02-12T14:13Z [----] followers, [----] engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"
X Link @BiopharmIQ 2026-02-08T18:59Z 28.9K followers, 19.6K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing